NPCE - NASDAQ

NeuroPace, Inc.

NPCE·NASDAQ

$16.65

+2.2%

HealthcareMedical - Devices

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$567.66M

EPS-0.6600

P/E Ratio-25.23

Earnings Date08/11/2026

npce

Accumulated Other Comprehensive Income (Loss)

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

NeuroPace, Inc. Competitors Analysis of Accumulated Other Comprehensive Income (Loss)

NPCE · NASDAQ

Company	Accumulated Other Comprehensive Income (Loss)	CAGR 3Y	CAGR 5Y	CAGR 10Y
NeuroPace, Inc. NASDAQ:NPCE	0.00	N/A	N/A	N/A
Delcath Systems, Inc. NASDAQ:DCTH	575.00K	62.1%	99.9%	N/A
Senseonics Holdings, Inc. NASDAQ:SENS	69.00K	N/A	N/A	N/A
CVRx, Inc. NASDAQ:CVRX	-203.00K	N/A	N/A	N/A
Aldeyra Therapeutics, Inc. NASDAQ:ALDX	0.00	N/A	N/A	N/A
RxSight, Inc. NASDAQ:RXST	53.00K	N/A	N/A	N/A
Genelux Corporation NASDAQ:GNLX	9.00K	-13.7%	35.1%	N/A
908 Devices Inc. NASDAQ:MASS	54.00K	-65.9%	N/A	N/A
Cerus Corporation NASDAQ:CERS	-156.00K	N/A	N/A	N/A
Sight Sciences, Inc. NASDAQ:SGHT	0.00	N/A	N/A	N/A

NeuroPace, Inc. Fair Value Envelope

NPCE · NASDAQ

Our analysis suggests that NPCE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $16.65, this represents a potential HIDDEN relative to our calculated worth for NeuroPace, Inc..

HIDDEN

Intrinsic Value

Current Price: $16.65

Related Guides

Blog Categories

Continue your NPCE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.